Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Jiang, Minghuan ^a   Yang, Shimin ^a   Yan, Kangkang ^a   Liu, Jun ^a   Zhao, Jun ^a   Fang, Yu ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOPHYLLINE; AMITRIPTYLINE; AMLODIPINE; AMOXICILLIN; ATORVASTATIN; BECLOMETASONE; CAPTOPRIL; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DICLOFENAC; ENALAPRIL; FLUOXETINE; GENERIC DRUG; GLICLAZIDE; LISINOPRIL; LORATADINE; LOSARTAN; METFORMIN; METRONIDAZOLE; NIFEDIPINE; OMEPRAZOLE; RANITIDINE; SALBUTAMOL; SIMVASTATIN;

ARTHRITIS; ARTICLE; ASTHMA; CHILDHOOD DISEASE; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DRUG COST; DRUG SURVEILLANCE PROGRAM; EPILEPSY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCOME; PEPTIC ULCER; PHARMACY; PUBLIC HOSPITAL; REFERENCE DATABASE; RELIABILITY; RESPIRATORY TRACT INFECTION; ULCER; VIRUS INFECTION;

CHINA; COMMERCE; DATA COLLECTION; DRUG PRESCRIPTIONS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 84880974731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070836     Document Type: Article

References (34)

1. World Health Organization (2011) The World Medicines Situation 2011-Access to Essential Medicines as Part of the Right to Health. Available: http://apps.who.int/medicinedocs/en/m/abstract/Js18772en/. Accessed 19 February 2012.
2. Ministry of Health (2011) Chinese health statistical digest 2011. Available: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohwsbwstjxxzx/s7967/201105/51862.htm. Accessed 16 February 2012.
3. OECD Library (2010) Health at a glance: Europe 2010. Available: http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe-2010_health_glance-2010-en. Accessed 4 June 2011.
4. Sun Q, Santoro MA, Meng QY, Liu C, Eggleston K, (2008) Pharmaceutical policy in China. Health Affairs 27: 1042-1050.
5. The State Council (2009) Chinese Communist Party Central Committee and the State Council: Opinions on deepening health sector reform. Available: http://www.gov.cn/jrzg/2009-04/06/content_1278721.htm. Accessed 3 June 2011.
6. The Shaanxi government (2009) Available: http://www.shaanxi.gov.cn/IssuedContentAction.do?dispatch=vContentListByColsupid&scope=sty&columninfoid=953#.Accessed 26 June 2011.
7. Alcorn T, Bao B, (2011) China progresses with health reform but challenges remain. Lancet 377: 1557-1558.
8. Guo Y, Shibuya KJ, Cheng G, Rao KQ, Lee LM, et al. (2010) Tracking China's health reform. Lancet 375: 1065-1068.
9. World Health Organization, Health Action International (2003) Measuring medicine prices, availability, affordability and price components 2nd edition. Available: http://www.haiweb.org/medicineprices/manual/documents.html. Accessed 13 June 2010.
10. Sun Q (2004) A survey of medicine prices, availability, affordability and price components in Shandong Province. Available: http://www.haiweb.org/medicineprices/surveys/200411CN/survey_report.pdf. Accessed 16 April 2010.
11. Ye L (2006) A survey of medicine prices, availability and affordability in Shanghai, China using the WHO/HAI methodology. Available: http://www.haiweb.org/medicineprices/surveys/200609CNS/survey_report.pdf. Accessed 16 April 2010.
12. Yang H, Dib HH, Zhu MM, Qi G, Zhang XP, (2009) Prices, availability and affordability of essential medicines in rural areas of Hubei Province,China. Health Policy Plan 25: 219-229.
13. Guan XD, Liang HG, Xue YJ, Shi LW, (2011) An analysis of China's national essential medicines policy. J Public Health Policy 32: 305-19.
14. Xiao Y, Zhao K, Bishai DM, Peters DH(2012) Essential drugs policy in three rural counties in China: What does a complexity lens add? Soc Sci Med. http://dx.doi.org/10.1016/j.socscimed.2012.09.034.
15. Tian X, Song YR, Zhang XP, (2012) National Essential Medicines List and policy practice: A case study of China's health care reform. BMC Health Serv Res 12: 401.
16. Yang LP, Liu CJ, Ferrier JA, Zhou W, Zhang XP (2012) The impact of the National Essential Medicines Policy on prescribing behaviors in primary care facilities in Hubei province of China. Health Policy Plan: 1-11.
17. The Shaanxi Provincial Department of Health (2010) Shaanxi government procurement office. Available: http://www.sxsyxcg.cn/common/default.aspx. Accessed 16 April 2010.
18. World Health Organization, Health Action International (2008) Measuring medicine prices, availability, affordability and price components 2nd edition. Available: http://www.haiweb.org/medicineprices/surveys.php. Accessed 7 June 2010.
19. MSH (2009) International drug price indicator guide, 2009 edition. Boston: Management Sciences for Health. Available: http://erc.msh.org/dmpguide/index.cfm?language=english&action=newyear&display=yes&module=dmp&year=2009. Accessed 12 June 2010.
20. Gelders S, Ewen M, Noguchi N, Laing R (2006) Price, availability and affordability: An international comparison of chronic disease medicines. World Health Organization and Health Action International, Cairo, 2006. Available: http://mednet3.who.int/medprices/CHRONIC.pdf. Accessed 8 July 2010.
21. Department of Human Resources and Social Security of Shaanxi Province(2010) The lowest wage standard in Shaanxi Province. Available: http://www.shaanxihrss.gov.cn/Html/2010-5-11/093523.Html. Accessed 12 July 2010.
22. The Ministry of Health (2009) The Chinese national EML. Available: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohywzc/s3580/200908/42506.htm. Accessed 26 June 2012.
23. Yang SM, Yu F (2010) Medicine prices, availability and affordability survey in Shaanxi Province, Western China. Available: http://www.haiweb.org/medicineprices/surveys/201009CNX/sdocs/survey_report_shaanxi_Final.pdf. Accessed 20 June 2012.
24. Babar ZU, Ibrahim MI, Singh H, Bukahri NI, Creese A, (2007) Evaluating drug prices availability, affordability, and price components: Implications for access to drugs in Malaysia. PLoS Med 4: 466-474.
25. Kotwani A (2003) Medicine prices in the state of Rajasthan, India. Available: http://www.haiweb.org/medicineprices/surveys/200306IN/survey_report.pdf. Accessed 26 June 2012.
26. Lakshmi Suresh PK (2004) Medicine prices and availability in the state of Karnataka, India 2004. Available: http://www.haiweb.org/GlobalDatabase/Main.htm. Accessed 26 June 2012.
27. Shoba I (2004) Medicine prices and availability in the state of Chennai,India. Available: http://www.haiweb.org/GlobalDatabase/Main.htm. Accessed 26 June 2012.
28. Singal GL (2004) Medicine prices and availability in the state of Harayana, India. Available: http://www.haiweb.org/GlobalDatabase/Main.htm. Accessed 26 June 2012.
29. Raman K (2004) Available:http://www.haiweb.org/medicineprices/surveys.php.Accessed 26 June 2012.
30. Archana P, Vijay T, Kunda G (2005) Medicine pricing, availability and affordability: report of four regions, Maharashtra, India. Available: http://www.haiweb.org/medicineprices/surveys/200501IG/survey_report.pdf. Accessed 24 April 2011.
31. Tripathi SK, Dey D, Hazra A (2005) Medicine prices and availability in the state of West Bengal, India. Available: http://www.haiweb.org/medicineprices/surveys/200412IW/survey_report.pdf. Accessed 26 June 2012.
32. Kotwani A (2011) Medicine prices, availability, affordability and medicine price components in NCT, Delhi: WHO/HAI methodology. Available: http://www.haiweb.org/medicineprices/surveys/201107IND/sdocs/ReportFinal_Delhi%20Medicine%20Price%20Survey_KotwaniA_Web.pdf. Accessed 26 June 2012.
33. Yip WC, Hsiao WC, Chen W, Hu SL, Ma J, et al. (2012) Early appraisal of China's huge and complex health-care reforms. Lancet 379: 833-842.
34. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R, (2009) Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373: 240-249.